Why the study?
Does endothelial dysfunction, measured by reactive hyperaemia, predict adverse outcomes in patients with congestive heart failure?
Population
242 patients with congestive heart failure (CHF)
Design
Cohort
Follow-up
5 years
Authors
Loading...
Endothelial dysfunction assessment may refine HF prognostication; hypothesis-generating and requires prospective validation before clinical adoption.
Does endothelial dysfunction, measured by reactive hyperaemia, predict adverse outcomes in patients with congestive heart failure?
Endothelial dysfunction, measured by post-hyperaemia forearm blood flow, is an independent predictor of major adverse events in patients with congestive heart failure.
Berrazueta et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: